DBV Technologies S.A. (DBVT)
NasdaqCM: DBVT
· リアルタイム株価 · USD
14.67
+0.65 (4.64%)
終値時点: Aug 17, 2026, 3:59 PM
DBV Technologies S.A. (DBVT) Stock Price, Analysis & Data
4.64% (1D)
DBVTについて
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy ...
企業情報の全文決算サプライズ
DBV S.A.はJul 16, 2026に四半期決算を発表しました:
2ページ中1ページ
